Theravance Biopharma, Inc. (21) | Business Operations (5)

Browse by Subcategory

Recent Contracts

Settlement Agreement by and between Ann Brady and Theravance Biopharma Ireland Limited, dated November 2, 2021 (Filed With SEC on February 28, 2022)
Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015 (Filed With SEC on February 26, 2021)
License and Collaboration Agreement by and between Theravance Biopharma Ireland Limited and Janssen Biotech, Inc. dated as of February 5, 2018 (Filed With SEC on February 26, 2021)
Cooperation Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020 (Filed With SEC on June 25, 2020)
Amendment No. 1 to the Development and Commercialization Agreement by and between Theravance Biopharma Ireland Limited and Mylan Ireland Limited, dated June 12, 2019 (Filed With SEC on August 5, 2019)